GRAVINA, Antonietta Gerarda
 Distribuzione geografica
Continente #
EU - Europa 2.707
NA - Nord America 2.392
AS - Asia 547
SA - Sud America 15
AF - Africa 8
OC - Oceania 4
Totale 5.673
Nazione #
US - Stati Uniti d'America 2.379
IE - Irlanda 842
IT - Italia 691
UA - Ucraina 275
GB - Regno Unito 252
SG - Singapore 226
DE - Germania 196
CN - Cina 178
FR - Francia 111
SE - Svezia 92
FI - Finlandia 89
GR - Grecia 53
TR - Turchia 51
KR - Corea 28
PL - Polonia 25
VN - Vietnam 25
NL - Olanda 23
BE - Belgio 18
RU - Federazione Russa 16
IN - India 14
AT - Austria 10
BR - Brasile 10
PK - Pakistan 10
CA - Canada 9
CZ - Repubblica Ceca 4
HK - Hong Kong 4
IR - Iran 4
SN - Senegal 4
AU - Australia 3
JP - Giappone 3
MK - Macedonia 3
MX - Messico 3
BO - Bolivia 2
ES - Italia 2
NG - Nigeria 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
ET - Etiopia 1
ID - Indonesia 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
Totale 5.673
Città #
Dublin 837
Chandler 442
Jacksonville 418
Naples 226
Santa Clara 161
Singapore 142
Princeton 105
New York 89
Roxbury 84
Boardman 74
Ann Arbor 71
Beijing 66
Cambridge 58
Medford 54
Bremen 53
Wilmington 47
Woodbridge 41
Munich 36
Caserta 32
Seoul 26
Des Moines 24
Dong Ket 24
Kraków 24
San Mateo 24
Nanjing 22
Mountain View 19
Napoli 19
Brussels 18
Paris 18
Amsterdam 17
Aversa 17
Boydton 15
Ashburn 13
Helsinki 13
Los Angeles 13
Jinan 11
Lappeenranta 11
Milan 11
Rome 10
Shenyang 10
Angers 9
Atella 8
Sennori 8
Vienna 8
Houston 7
Norwalk 7
Porto Alegre 7
Auburn Hills 6
Guangzhou 6
Lahore 6
Seregno 6
Bacoli 5
Brighton 5
Buffalo 5
Hyderabad 5
Kunming 5
Lanzhou 5
Nuremberg 5
Pomezia 5
Secaucus 5
St Petersburg 5
Villaricca 5
Cattolica 4
Hangzhou 4
Lübeck 4
Mumbai 4
Portici 4
Salerno 4
Torre Annunziata 4
Atlanta 3
Bisaccia 3
Changsha 3
Düsseldorf 3
Gatchina 3
Lodi 3
Nanchang 3
Nola 3
Panettieri 3
Seattle 3
Serino 3
Turin 3
Vasto 3
Arnhem 2
Berlin 2
Bologna 2
Brno 2
Casoria 2
Catania 2
Cesena 2
Changchun 2
Chicago 2
Civitavecchia 2
Clonakilty 2
Colomiers 2
Erding 2
Forlì 2
Frankfurt am Main 2
Haikou 2
Hanover 2
Hebei 2
Totale 3.631
Nome #
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 104
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 103
Intrafamilial spread of Helicobacter pylori infection 94
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 76
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 74
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 74
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 73
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 73
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 73
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis 71
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 70
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 69
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 69
Caso di interferenza tra video capsula e pacemaker in paziente portatore di pacemaker per aritmia 67
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 67
Crohn’s disease and skin 66
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 66
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 65
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 64
The burden of anaemia in patients with inflammatory bowel diseases 64
Sequential therapy for eradication of Helicobacter pilori infection 63
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 61
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 61
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 60
Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans. 60
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 59
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 59
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 58
Comparison of Timing to Develop Anti-Drug Antibodies to Infliximab and Adalimumab Between Adult and Pediatric Age Groups, Males and Females 58
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 57
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 57
CARDIAC PACEMAKER AND WIRELESS CAPSULE ENDOSCOPY INTERFERENCE: CASE REPORT IN A PATIENT WITH GASTRIC VASCULAR ECTASIAS 56
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 56
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 55
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 54
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 53
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 52
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 52
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 52
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 51
Diffusione intrafamiliare dell’infezione da Helicobacter pylori. 50
Infezione da Helicobacter pylori: fisiopatologia e clinica 50
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 50
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials 50
Prevalence of lesions detected at upper endoscopy: an Italian Survey. 49
Endoscopic diagnosis of secondary rectal teratoma in a young woman with constipation and positive fecal occult blood test 49
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 49
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments 48
Ulcerative colitis associated with leukocytoclastic vasculitis of the skin 48
Apple polyphenol extracts prevent aspirin-induced damage to the rat gastric mucosa 48
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 47
Bone Alterations in Inflammatory Bowel Diseases: Role of Osteoprotegerin 47
Eradication of Helicobacter pylori infection: which regimen first? 45
Levofloxacin-containing quadruple concomitant therapy for eradication of H. pylori infection. 45
Levofloxacin-based sequential therapy vs clarithromycin-based sequential therapy for eradication of H. pylori infection. 45
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 45
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. 44
COELIAC DISEASE AND C VIRUS-RELATED CHRONIC HEPATITIS: A NON ASSOCIATION 43
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 43
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 42
A randomized controlled trial of acarbose in hepatic encephalopathy 41
EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: A PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY 41
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis 40
Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance 40
Pyoderma gangrenosum: an updated review 40
The role of Helicobacter pylori infection and small intestinal bacterial overgrowth in rosacea 40
Cyclic vomiting in a young patient with superior mesenteric artery syndrome 40
Secondary Extramedullary Plasmacytoma of the Duodenum: An Unusual Endoscopic Presentation 40
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational study 40
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 39
Five-Day Quadruple Concomitant Therapy vs Ten-Day Sequential Therapy for Eradication of H. pylori Infection. 39
INTERFERENCE BETWEEN PACEMAKER AND VIDEO CAPUSLE ENDOSCOPY: CASE REPORT 39
Percutaneous endoscopic gastrostomy for critically ill patients in a general intensive care unit. 39
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 39
Performance of a multi-compounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease 39
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 38
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 38
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer 38
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 38
Inflammatory Bowel Diseases: The Role of Gut Microbiota 38
Detection of Gastric Precancerous Conditions in Daily Clinical Practice: A Nationwide Survey 36
Telaprevir- or boceprevir-based triple-therapy in patients with HCV infection genotype 1: on-treatment efficacy and data on safety 36
Light alcohol drinking and the risk of cancer development: a controversial relationship 36
Cycloxygenase-2 and vascular endothelial growth factor expression in ileal pouch anal anastomosis. 35
Gender difference in dermatological adverse effects during antibodies anti-TNFα therapy in chronic inflammatory bowel disease 35
Optimized non-bismuth quadruple therapies cure most patients infected with Helicobacter pylori despite resistance to Clarithromycin and Metronidazole 35
Colonic angiodysplasia with adenomatous epithelial foci 33
Gastric xanthomatosis associated with gastric intestinal metaplasia in a dyspeptic patient 33
Fourteen-day, high-dose acid suppression, non-bismuth quadruple therapies (“hybrid” vs. “concomitant”) for Helicobacter pylori eradication: a randomised trial 33
Levofloxacin-based sequential therapy for eradication of H. pylori infection. 33
Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets 33
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 32
Does gender influence upper gastrointestinal symptoms and endoscopic diagnosis? 32
Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study 32
Prevalence of nonpolypoid colorectal neoplasia: an Italian multi center observational study 31
Five-day quadruple concomitant therpy vs ten-day sequential therapy for eradication of H. pylori infection. 31
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 31
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 30
Dynamic shifts in lung cytokine patterns in post-COVID-19 interstitial lung disease patients: a pilot study 29
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 29
Totale 4.994
Categoria #
all - tutte 28.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020269 0 0 0 0 66 14 88 22 26 18 29 6
2020/2021691 63 10 74 39 97 13 93 65 15 97 81 44
2021/2022770 35 5 8 33 200 9 53 24 35 45 116 207
2022/20231.726 138 58 30 158 201 129 11 114 800 21 35 31
2023/2024932 57 38 43 64 240 113 28 17 7 40 96 189
2024/2025626 20 46 83 138 339 0 0 0 0 0 0 0
Totale 5.931